Apoptosis and post-infarction left ventricular remodeling.

Apoptosis is a common pathological feature in acute myocardial infarction (AMI), however, its role in the later phases (>10 days) of AMI and in post-infarction left ventricular remodeling has not been characterized. The aim of the study was to identify signs of ongoing cell apoptosis late post AMI. Sixteen hearts were collected at autopsy from subjects 12 to 62 days after the onset of AMI. In situ end-labeling of DNA fragmentation (TUNEL) and co-staining with caspase-3 were performed. Double-positive cells were defined as apoptotic and the apoptotic rate was calculated. Values are expressed as median and interquartile range. Co-stainings with muscle-actin, splicing factor (SC35), PCNA, bax and bcl-2 were also performed. Apoptotic rates at site of infarction [25.4% (17.0-28.4%)] were significantly higher v those at remote regions [0.7% (0.5-0.8%) P<0.001] and significantly correlated to left ventricular longitudinal and transverse diameters [ r = +0.70 (P=0.016) and r = +0.63 (P=0.004) respectively]. Moreover, in subjects with persistently occluded infarct-related artery (14 cases) there was a significantly higher apoptotic rate at the site of infarction compared to those (2 cases) with patent artery [26.0% (21.9-28.5%) v 4.5% (0.6% and 8,4%);P=0.033]. A significantly greater bax immuno-reactivity close to the infarction v remote areas was found (P<0.001). High grade apoptosis is present at sites of infarction in the later phases post AMI. This is more evident if the infarct-related artery is persistently occluded and signs of ventricular remodeling are present. These data may provide an explanation of progressive late left ventricular dysfunction.

[1]  P. Anversa,et al.  Evidence that human cardiac myocytes divide after myocardial infarction. , 2001, The New England journal of medicine.

[2]  I. Tikkanen,et al.  Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. , 2001, American journal of physiology. Heart and circulatory physiology.

[3]  L. Pierard,et al.  Full recovery of contraction late after acute myocardial infarction: determinants and early predictors , 2001, Heart.

[4]  M. Johnston,et al.  Apoptosis Has a Prolonged Role in the Neurodegeneration after Hypoxic Ischemia in the Newborn Rat , 2000, The Journal of Neuroscience.

[5]  P. Doevendans,et al.  Visualisation of cell death in vivo in patients with acute myocardial infarction , 2000, The Lancet.

[6]  F. Eberli,et al.  Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. , 2000, American journal of physiology. Heart and circulatory physiology.

[7]  T. N. James,et al.  Homage to James B. Herrick: a contemporary look at myocardial infarction and at sickle-cell heart disease: the 32nd Annual Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association. , 2000, Circulation.

[8]  G. Stassi,et al.  Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. , 1999, Circulation.

[9]  T. Aoyama,et al.  Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. , 1999, Circulation.

[10]  Pulkki,et al.  Cardiomyocyte apoptosis and progression of heart failure to transplantation , 1999, European journal of clinical investigation.

[11]  A. Saraste Morphologic criteria and detection of apoptosis , 1999, Herz.

[12]  G. Takemura,et al.  "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with In situ nick end-labeling. , 1998, Circulation.

[13]  Lawrence Buja,et al.  Modes of myocardial cell injury and cell death in ischemic heart disease. , 1998, Circulation.

[14]  M. Berlan,et al.  Developmental remodeling and shortening of the cardiac outflow tract involves myocyte programmed cell death. , 1998, Development.

[15]  S. Izumo,et al.  Apoptosis: basic mechanisms and implications for cardiovascular disease. , 1998, Circulation research.

[16]  G. D. De Meyer,et al.  RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. , 1998, The American journal of pathology.

[17]  S. Radinovic,et al.  Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat. , 1998, Journal of molecular and cellular cardiology.

[18]  K. Maehara,et al.  Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. , 1998, Circulation.

[19]  S. Nagata,et al.  Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis , 1998, Nature.

[20]  T. Yue,et al.  Apoptosis and congestive heart failure. , 1997, Trends in cardiovascular medicine.

[21]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[22]  R. Gascoyne,et al.  Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. , 1997, Cancer research.

[23]  J. Veinot,et al.  Early apoptosis in human myocardial infarcts. , 1997, Human pathology.

[24]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[25]  Y. Hayakawa,et al.  Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. , 1996, Circulation.

[26]  S. Chierchia,et al.  Coronary recanalization by elective angioplasty prevents ventricular dilation after anterior myocardial infarction. , 1996, Journal of the American College of Cardiology.

[27]  P. Anversa,et al.  Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. , 1996, Journal of molecular and cellular cardiology.

[28]  John Calvin Reed,et al.  Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[29]  G. Barnett,et al.  Interleukin-1β-converting Enzyme Mediates Cisplatin-induced Apoptosis in Malignant Glioma Cells , 1995 .

[30]  E. Sonnenblick,et al.  Stretch-induced programmed myocyte cell death. , 1995, The Journal of clinical investigation.

[31]  John Calvin Reed,et al.  Structure-Function Analysis of Bcl-2 Protein , 1995, The Journal of Biological Chemistry.

[32]  E. Braunwald,et al.  Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. , 1993, Circulation.

[33]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[34]  J. Kerr,et al.  Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. , 1982, Pathology annual.